Specialist Profile

Cosmetic & Plastic Surgery Center

855.383.7843

Schedule a Consultation

Risal Djohan, MD

Risal Djohan, MD

Appointed: 2003

Risal Djohan, MD
Department: Plastic Surgery

Biographical Sketch

Risal Djohan, MD, is a plastic surgeon at Cleveland Clinic. He received his medical training at Finch University of Health Sciences, Chicago Medical School, and went on to complete a residency in General Surgery through Catholic Health Partners, Columbus Hospital. He also completed fellowships in plastic surgery at the University of Chicago Hospitals and an aesthetic surgery fellowship at Cleveland Clinic.

Dr. Djohan’s special interests include facial cosmetic and plastic surgery, including face lifts (rhytidectomy) and cosmetic nose surgery (rhinoplasty), as well as Botox® and injectable fillers. Additionally, his interests include breast surgery, liposuction and tummy tucks (abdominoplasty).

He has been board-certified in both general surgery and plastic surgery. His many clinical interests include microvascular surgery and reconstruction of the breast.

Education & Fellowships

Fellowship - Cleveland Clinic
Aesthetic Surgery
Cleveland, OH USA
2003
Fellowship - University of Chicago Hospitals
Plastic Surgery
Chicago, IL USA
2002
Fellowship - University of Chicago Hospitals
Plastic Surgery
Chicago, IL USA
2000
Residency - Catholic Health Partners-Columbus Hospital
General Surgery
Chicago, IL USA
1999
Internship - Catholic Health Partners-Columbus Hospital
General Surgery
Chicago, IL USA
1995
Medical School - Finch University of Health Sciences-Chicago Medical School
Chicago, IL USA
1994

Certifications

  • Plastic Surgery

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 10/7/2013, Dr. Djohan has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Djohan received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • HealthPoint Biotherapeutics, Ltd.
  • Smith & Nephew plc
  • ViOptix, Inc

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English